You have 2 free disease views remaining today. Register for more view, it is 100% free →
congenital myasthenic syndrome 19
Description
Congenital Myasthenic Syndrome (CMS) Description
Congenital myasthenic syndrome (CMS) is a group of inherited conditions that are present from birth or early childhood [6]. It is characterized by muscle weakness (myasthenia) that worsens with physical exertion [2]. The symptoms can range from mild to severe, and may include difficulty breathing, swallowing, speaking, and moving the eyes and eyelids [3].
Key Features:
- Muscle weakness that worsens with physical exertion
- Symptoms typically begin in early childhood or at birth
- Can affect various muscle groups, including those controlling breathing, swallowing, speaking, and eye movement
- Severity of symptoms can vary greatly from person to person
Causes:
CMS is caused by defective genes that impair the transmission of messages from nerves to muscles [4]. This impairment leads to muscle weakness and fatigue. There are many different genetic mutations that can cause CMS, making it a heterogeneous group of conditions.
Note: The information provided above is based on search results 6, 2, 3, and 4 in the context block.
Additional Characteristics
- A group of inherited conditions present from birth or early childhood
- Characterized by muscle weakness that worsens with physical exertion
- Symptoms can range from mild to severe, including difficulty breathing, swallowing, speaking, and moving the eyes and eyelids
- Caused by defective genes impairing nerve-to-muscle message transmission
Signs and Symptoms
Signs and Symptoms of Congenital Myasthenic Syndrome
Congenital myasthenic syndromes (CMS) are a group of genetic conditions that all include muscle weakness that gets worse with physical activity. The signs and symptoms of CMS vary based on the type, but they can be quite diverse.
Common Signs and Symptoms:
- Muscle fatigue and weakness triggered by physical activity [2]
- Decreased movement in the womb (polyhydramnios) [7]
- Stiff joints (arthrogryposis), reduced movements, weak suck and cry from birth [7]
- Difficulty feeding, swallowing, and breathing difficulties [7]
- Eyelid ptosis (drooping eyelids), oculoparesis (weak eye muscles), and variable but frequently moderate to severe limb muscle weakness [9]
Other Possible Symptoms:
- Floppiness in infancy
- Choking spells
- Feeding and breathing difficulties
- Hanging eye lids
It's essential to note that the severity of symptoms can range from mild to severe, and some individuals may experience life-threatening symptoms like breathing difficulties. The earlier the symptoms appear, the more pronounced the disease is likely to be [3].
References:
[1] Symptoms vary based on type but could include muscle fatigue and weakness triggered by physical activity. [2] Muscle fatigue and weakness triggered by physical activity. [3] Signs and symptoms of congenital myasthenic syndromes (CMS) usually have a congenital onset, but the disease can manifest in children and even in adults. [7] The following symptoms may be noticed in someone with Congenital myasthenic syndrome (CMS): in the womb: decreased movement and too much amniotic fluid (polyhydramnios) from birth: stiff joints (arthrogryposis), reduced movements, a weak suck and cry, difficulty feeding, swallowing and possibly episodic breathing difficulties [9] Nearly all patients have eyelid ptosis, oculoparesis that often becomes fixed, and variable but frequently moderate to severe limb muscle weakness.
Additional Symptoms
- Choking spells
- Feeding and breathing difficulties
- Muscle fatigue and weakness triggered by physical activity
- Hanging eye lids
- Decreased movement in the womb (polyhydramnios)
- Stiff joints (arthrogryposis), reduced movements, weak suck and cry from birth
- Difficulty feeding, swallowing, and breathing difficulties
- Eyelid ptosis (drooping eyelids), oculoparesis (weak eye muscles), and variable but frequently moderate to severe limb muscle weakness
- Floppiness in infancy
Diagnostic Tests
Diagnostic Tests for Congenital Myasthenic Syndrome (CMS)
Congenital Myasthenic Syndrome (CMS) is a rare genetic disorder that affects the nerve-muscle connection, leading to muscle weakness and fatigue. Diagnosing CMS can be challenging, but various tests can help confirm the condition.
Blood Tests
- Genetic testing helps detect the gene change causing symptoms [3].
- Blood tests may be ordered to detect antibodies to the ACh receptor, which is consistent with myasthenia gravis (MG) [1].
Genetic Testing
- Targeted genetic testing for CMS mutations in previously identified CMS genes is available but should be used based on specific clinical criteria [2].
- The Invitae Congenital Myasthenic Syndrome Panel analyzes genes associated with congenital myasthenic syndrome (CMS), a heterogeneous group of neuromuscular disorders [5].
Electrophysiological Tests
- Electromyography (EMG) and nerve conduction studies may be performed to assess muscle function and detect abnormalities [6].
- These tests can help exclude other causes of symptoms and support the diagnosis of CMS.
Other Diagnostic Tools
- A 21 gene panel, including assessment of non-coding variants, is ideal for patients with a clinical suspicion of congenital myasthenic syndrome (CMS) [8].
- A neurologist will make a clinical diagnosis and carry out tests for CMS, which may include taking a clinical history and performing physical examinations [7].
References
[1] Context result 1 [2] Context result 2 [3] Context result 3 [5] Context result 5 [6] Context result 6 [7] Context result 7 [8] Context result 8
Additional Diagnostic Tests
- Blood Tests: Genetic testing, Blood tests for ACh receptor antibodies
- Genetic Testing: Targeted genetic testing for CMS mutations, Invitae Congenital Myasthenic Syndrome Panel
- Electrophysiological Tests: Electromyography (EMG), Nerve conduction studies
- Other Diagnostic Tools: 21 gene panel, Clinical history and physical examination
Treatment
Treatment Options for Congenital Myasthenic Syndrome
Congenital myasthenic syndromes (CMS) are a group of rare genetic disorders that affect the nerve-muscle connection, leading to muscle weakness and fatigue. While there is no cure for CMS, various drug treatments can help manage symptoms and improve quality of life.
Medications Used in CMS Treatment
- Cholinesterase inhibitors: These medications, such as pyridostigmine (Mestinon), work by increasing the levels of acetylcholine (ACh) in the body, which is essential for proper muscle function [2].
- β-Adrenergic agonists: Salbutamol and ephedrine are examples of medications that can be used as first-line treatments for CMS, as they help improve muscle strength and reduce fatigue [4].
- Open-channel blockers: These medications can also be effective in treating CMS by blocking the action of acetylcholine receptors at the neuromuscular junction [6].
Other Treatment Options
- IVIG (Intravenous Immunoglobulin): This treatment involves administering antibodies to help reduce muscle weakness and fatigue.
- PE (Plasma Exchange): Similar to IVIG, plasma exchange can also be used to treat CMS by removing abnormal antibodies from the blood.
Important Considerations
- Medications used in CMS treatment may vary depending on the specific genetic mutation causing the condition [11].
- Some medications, such as antibiotics and cardiovascular drugs, should be avoided in people with CMS due to potential interactions or adverse effects [9].
It's essential for individuals with CMS to work closely with their healthcare providers to determine the best course of treatment and manage symptoms effectively.
Differential Diagnosis
The differential diagnosis of congenital myasthenic syndromes (CMS) involves a range of conditions that can present with similar symptoms to CMS. Some of the key differential diagnoses include:
- Spinal muscular atrophy: This is a genetic disorder that affects the nerve cells responsible for controlling voluntary muscle movement, leading to muscle weakness and wasting [7].
- Myasthenia gravis: This is an autoimmune disease that causes muscle weakness and fatigue, particularly affecting the muscles of the face, neck, and limbs [10].
- Motor neuron disease: This is a group of conditions that affect the nerve cells responsible for controlling voluntary muscle movement, leading to muscle weakness and wasting [8].
- Peripheral neuropathy: This refers to damage or dysfunction of the peripheral nerves, which can cause muscle weakness, numbness, and pain [9].
It's worth noting that the differential diagnosis of CMS is complex and requires a comprehensive evaluation of the patient's medical history, physical examination, and laboratory tests. A suspected diagnosis of CMS is often based on typical clinical features, decremental responses of 10% or more on repetitive nerve stimulation (RNS) and/or abnormal jitter and block on single-fibre EMG [13].
In terms of specific conditions that can be ruled out in the differential diagnosis of CMS, these include:
- Congestive heart failure: This is a condition where the heart is unable to pump enough blood to meet the body's needs, leading to symptoms such as shortness of breath and fatigue.
- Pulmonary embolism: This is a blockage of an artery in the lung, which can cause symptoms such as chest pain and difficulty breathing.
- Acute myocardial infarction: This is a heart attack caused by a blockage of one or more coronary arteries.
These conditions are typically ruled out through a combination of medical history, physical examination, and laboratory tests, including electrocardiogram (ECG), chest X-ray, and blood tests.
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_5024
- owl#annotatedSource
- t370297
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0110673
- core#notation
- DOID:0110673
- oboInOwl#hasDbXref
- MIM:616720
- oboInOwl#hasExactSynonym
- CMS19
- rdf-schema#label
- congenital myasthenic syndrome 19
- IAO_0000115
- A congenital myasthenic syndrome characterized by autosomal recessive inheritance of defects in the neuromuscular junction resulting in generalized muscle weakness, exercise intolerance, and respiratory insufficiency that has_material_basis_in homozygous mutation in the COL13A1 gene on chromosome 10q22.
- rdf-schema#subClassOf
- t370638
- RO_0002452
- http://purl.obolibrary.org/obo/SYMP_0000094
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- RO_0004019
- http://purl.obolibrary.org/obo/HP_0001197
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.